| Name | Title | Contact Details |
|---|
The story of Control Solutions, now a partner with ADAMA Consumer & Professional Solutions, began in 1958 when the Boyd family purchased a small Pasadena, Texas pest control company. Before long, Ford`s Pest Control grew to become Ford`s Chemical and Service in 1976. Later, in 1985, Control Solutions, Inc. (CSI) was created to distribute Ford`s products to the professional and consumer markets. Ford`s success and growth in formulating PCO, Animal Health and Consumer products drew the attention of Roussel Bio Corporation, which acquired Ford`s in 1989. Control Solutions continued as a family owned business and built on to the commitment of serving the professional pest control and retail markets after the Ford`s sale to Roussel. Since that time, CSI has added product lines for the Industrial, Lawn and Garden, Animal Health and Biocide markets, and is working with 80 + distributors serving those markets. Control Solutions maintains relationships with chemical manufacturers worldwide and maintains a ready supply of products in numerous distribution warehouses across the U.S. Today our partnership with ADAMA (www.adama.com) multiplies Control Solutions` agility in continuously adding new products to meet the needs of professionals and homeowners. The one constant since the beginning in 1958 is our mission focus: to seek out and distribute effective and economical solutions for our customers.
Task International USA Inc is a Keyport, NJ-based company in the Manufacturing sector.
Wabash Valley Svc Co is a Mc Leansboro, IL-based company in the Manufacturing sector.
West Laboratories Inc is a Kankakee, IL-based company in the Manufacturing sector.
Sirrus, a Chemical Start-up, based in Loveland, OH, USA and founded as Bioformix in 2009, has developed cost advantaged processes to produce reactive monomers at high purities. Its leading target monomer, diethyl methylene malonate, or DEMM, together with its derivatives, or MM-D, can be used in a variety of applications where customers in a broad range of markets value faster cure times, lower solvent usage and are faced with legislation restricting the use of incumbent formulation components. Sirrus has developed a robust patent portfolio, consisting of ~50 patents that address process technologies, methods of application, initiation, formulation and stabilization, as well as composition of matter for certain homopolymers, copolymers and hybrid polymers. Masanori Ikeda, President of Nippon Shokubai, said “It is rare to find a platform monomer company like Sirrus to provide best in class reactive monomers and materials to its customers. Combined with Sirrus` intellectual property position, track record of innovation and access to a broad range of customers and applications, the transaction is a strong strategic fit for Nippon Shokubai”.As a wholly owned operating subsidiary of Nippon Shokubai, Sirrus will have access to additional resources to accelerate the development and commercialization of DEMM and MM-D, including in the areas of manufacturing, regulatory, capital planning and sales and marketing. As part of the transaction, the management team of Sirrus will continue in their current roles. Moving forward, both companies will conduct collaborative operations for early establishment of supply chains and market entry, targeting the start-up of the first commercial plant in 2019